Milan, Italy- (WEBSITE ANNOUNCEMENT) – Deenova, announced today that in addition to the already obtained SA8000, ISO9001, ISO13485, ISO14001 and ISO45001 Certifications, last December Deenova also received the ISO/IEC 27001:2013 Information Security Management System certification after successfully completing the requirements and obtaining official accreditation by RINA , the authorized certification services.
Marco Spelta, Chief Information Officer at Deenova, stated: “Meeting the customer requests, ensuring the highest standards of security and quality, is the most important focus for us, so we follow the best practices certified by ISO/IEC 27001:2013: the international standard for an information security management system.”
ISO/IEC 27001 Information Security Management System certification is the leading international standard focused on information security, published by the International Organization for Standardization (ISO), in partnership with the International Electrotechnical Commission (IEC). It sets out the specification for an information security management system (ISMS).
The information security management system standard’s best-practice approach helps organisations manage their information security by addressing people, processes and technology.
RINA is a multinational company that helps clients build strong, successful businesses, with 160 years of experience across a wide range of industries. RINA Certification services provide an independent guarantee of compliance with associated regulatory standards, in order to support enterprises across all aspects of projects, operations, logistics and legislation.
Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere.
Deenova‘s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff.
Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.